Concepedia

Yu. F. Osmolovskaya

YF

Statistics

Publications

6

Citations

3.7K

H-Index

6

Active since

2015

Affiliations

National Medical Research Center of Cardiology(Current)

McMaster University

Universidad de La Frontera

Eli Lilly (United States)

Estudios Clínicos Latinoamérica

Yu. F. Osmolovskaya is an author at National Medical Research Center of Cardiology specializing in medicine, cardiology, and internal medicine.

ORCID

Publications per year

2015–2021

6

Publications

6

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne et al. · Indian Heart Journal · 2018 · 21 citations · Full text

, , +10

Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register

Natalia V. Safronova, Yu. F. Osmolovskaya, S. N. Тereschenko · Russian Journal of Cardiology · 2021 · 19 citations · Full text

, , +15

The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design

Yu. F. Osmolovskaya, Golitsyn Sp · Rational Pharmacotherapy in Cardiology · 2015 · 17 citations · Full text

, , +14

1–5 of 6